| Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. | |
| | |
MedLine Citation:
|
PMID: 16952435 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
One way to reach intracellular therapeutic targets in cells consists in the use of short nucleic acids which will bind specifically to on targets thanks to either Watson-Crick base pairing or protein nucleic acids recognition rules. Among these short nucleic acids an important class of therapeutic agents is antisense oligonucleotides and siRNAs. However, the major problem of nucleic acids is their poor stability in biological media. One method, among others, to solve the stability problem is the use of colloïdal carriers such as nanoparticles. Nanoparticles have already been applied with success to in vitro drug delivery to particular types of cells and in vivo in several experimental models. Many membrane and intracellular processes deal with nanosized structure (typically 100 nm) which are processed further through the recognition sites of receptors and enzymes. Thus non-viral nanoparticles are interesting candidates to present biochemical molecules such as nucleic acids and proteins to cells as well as to protect them in vivo during delivery. This review focuses on the recent developments in the design of nanotechnologies to improve the delivery of antisense oligonucleotides and siRNAs. |
| | |
Authors:
|
N Toub; C Malvy; E Fattal; P Couvreur |
Related Documents
:
|
15669315 - Particle phase acidity and oligomer formation in secondary organic aerosol. 3040395 - Reactions of nucleic acid bases with alpha-acetylenic esters. chemical modification of ... 15315365 - Detection and quantification of protein residues in food grade amino acids and nucleic ... 14331185 - Enrichment of serine-acceptor soluble rna by nucleic acid gels. 23201525 - Production of acetone, butanol, and ethanol from biomass of the green seaweed ulva lact... 3087925 - Toxoplasma-like sporozoa in an aborted equine fetus. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review Date: 2006-08-31 |
Journal Detail:
|
Title: Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie Volume: 60 ISSN: 0753-3322 ISO Abbreviation: Biomed. Pharmacother. Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-30 Completed Date: 2006-12-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8213295 Medline TA: Biomed Pharmacother Country: France |
Other Details:
|
Languages: eng Pagination: 607-20 Citation Subset: IM |
Affiliation:
|
Laboratoire de Physicochimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Faculté de Pharmacie, 5, rue Jean-Baptiste-Clement, 92286 Châtenay-Malabry cedex, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Carriers* Humans Nanotechnology* Oligonucleotides, Antisense / administration & dosage* RNA, Small Interfering / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Drug Carriers; 0/Oligonucleotides, Antisense; 0/RNA, Small Interfering |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA...
Next Document: Flavanone metabolism in healthy and tumor-bearing rats.